cjc 1295 ipamorelin increase testosterone CJC-1295 + Before & After Results Testosterone Therapy vs. Ipamorelin/CJC-1295: Which

The 2024 NICE guideline NG239 sets out a more intensive loading schedule for patients with neurological involvement precisely because their starting point is worse

Contraction-mediated injury represents a major pathological contributor to progressive muscle degeneration in muscular dystrophy, making therapies that attenuate this type of damage clinically relevant

Pooled Phase III analysis (n=816) Consistent VAT reductions across both trials with maintenance during continued therapy and regression toward baseline after stopping

Success depends on careful patient selection, proper protocol implementation, and ongoing monitoring